Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15632118 | 0.94 | HTT (0.36) | MAPTMAPK1NPSR1TSHRHSD17B10 | |
| SCHEMBL15632102 | 0.90 | CYP19A1 (0.30) | KDM4EATML3MBTL1CYP19A1PDE10A | |
| SCHEMBL15213685 | 0.90 | MAPT (0.39) | MAPTMAPK1NPSR1TSHRHSD17B10 | |
| SCHEMBL20426238 | 0.89 | KMT2A (0.37) | MAPTMAPK1NPSR1HPGDADORA2A | |
| SCHEMBL16357503 | 0.89 | KMT2A (0.37) | MAPTMAPK1NPSR1HPGDADORA2A | |
| SCHEMBL15632153 | 0.89 | KDM4E (0.33) | MAPTHPGDALDH1A1KDM4EATM | |
| SCHEMBL15213474 | 0.87 | MAPT (0.38) | MAPTMAPK1NPSR1TSHRHSD17B10 | |
| SCHEMBL16357554 | 0.86 | KDM4E (0.36) | MAPTMAPK1NPSR1TSHRHPGD | |
| SCHEMBL15213688 | 0.85 | L3MBTL1 (0.33) | MAPTMAPK1NPSR1TSHRHPGD | |
| SCHEMBL15632101 | 0.85 | KDM4E (0.34) | MAPTNPSR1TSHRKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230209861-A1 | LIGHT EMITTING DEVICE AND DISPLAY APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-29 | — | — | US | disclosed |
| EP-4135060-A2 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS COMPRISING LIGHT-EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2023-02-15 | — | — | EP | disclosed |
| US-20220407028-A1 | LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| US-20190148640-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-16 | — | — | US | disclosed |
| WO-2013122364-A2 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE THEREWITH | 덕산하이메탈(주) (KR) | 2013-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220407028-A1 | LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME | ALDH1A2, STRA6, DCX | MAPT 2188/4885MAPK1 2347/4885NPSR1 2714/4885 |
| US-20190148640-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, EML4, L1CAM | MAPT 1119/4885MAPK1 2750/4885NPSR1 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.